
GSK vs GYRE
$GSK vs $GYRE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs GYRE: the quick read
- ·GSK is the larger company by market cap ($99.15B vs $714M).
- ·GSK has been more active on our scanner (62 vs 14 alerts in 30 days).
- ·GYRE has the smaller float (15.4M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·GYRE trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·GSK draws far more of our scanner's attention, 62 unusual-volume alerts in 30 days against 14, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GSK is more than 139x the market cap of GYRE, so the same dollar of news moves GYRE far harder.
- ·GSK pays a dividend and GYRE does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: GSK is outperforming the other by roughly 5.8 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and GYRE on TheDesperateTrader.
- Is GSK or GYRE the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($99.15B vs $714M). GSK has been more active on our scanner (62 vs 14 alerts in 30 days). GYRE has the smaller float (15.4M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and GYRE?
- The differences that matter: GSK is roughly 139x the size of the other by market cap ($99.15B vs $714M); they trade at very different share prices ($49.51 vs $6.09); GSK sits at 35% of its 52-week range against 16% for GYRE; only GSK pays a dividend; our scanner flagged GSK 62 times in the last 30 days against 14 for GYRE. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and GYRE is more active right now?
- Right now GSK is at about 1.4x its normal volume and GYRE is at about 0.6x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or GYRE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.